Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2013 Feb 15;54(2):1378-83.
doi: 10.1167/iovs.12-11341.

Intervisit variability of visual parameters in Leber congenital amaurosis caused by RPE65 mutations

Affiliations
Comparative Study

Intervisit variability of visual parameters in Leber congenital amaurosis caused by RPE65 mutations

Alejandro J Roman et al. Invest Ophthalmol Vis Sci. .

Abstract

Purpose: To determine the intervisit variability of kinetic visual fields and visual acuity in patients with Leber congenital amaurosis (LCA) caused by mutations in the RPE65 (Retinal Pigment Epithelium-specific protein 65kDa) gene.

Methods: RPE65-LCA patients (n = 20; ages 11-40 years) were studied on at least two visits separated by fewer than 120 days using Goldmann visual field (GVF) and ETDRS visual acuity (VA) in a retrospective review. GVFs were quantified by computing the spherical coordinates of their vertices and calculating the solid angle subtended, and reported in normalized solid-angle units (nsu) as a percentage of average normal field extent. Repeatability coefficients were calculated using 95% confidence intervals on log(10)-converted variables.

Results: Visual field extents in RPE65-LCA spanned a wide range from 4 to 95 nsu. The repeatability coefficient was 0.248 (log(10)nsu), suggesting cutoffs for significant change (in nsu) of +77% for improvement and -44% for worsening. VA in RPE65-LCA ranged from logMAR = 0.14 to 1.96 (20/40 to 20/1250). The repeatability coefficient was 0.170 (logMAR) (±8.5 ETDRS letters). Comparisons with published studies of ungenotyped retinitis pigmentosa showed that the RPE65-LCA patients had higher variability in kinetic field extent. VA variability in RPE65-LCA fell within reported results for retinitis pigmentosa.

Conclusions: Variability data for GVF and VA are provided to permit interpretation of the significance of increases and decreases of these functional outcomes in ongoing and planned clinical trials of therapy for LCA caused by RPE65 mutations.

PubMed Disclaimer

Conflict of interest statement

Disclosure: A.J. Roman, None; A.V. Cideciyan, None; S.B. Schwartz, None; M.B. Olivares, None; E. Heon, None; S.G. Jacobson, None

Figures

Figure 1
Figure 1
Intervisit variability of kinetic visual fields in RPE65-LCA. (A) Visual field extent in one eye of patients with RPE65 mutations, measured by the same examiner and perimeter in two or three visits within a 120-day interval. Ordinate is in nsu; mean normal extent corresponds to 100 nsu. Bottom: Examples of Goldmann perimeter charts (shown as left eyes) recorded on different visits for four representative patients. (B) Variability shown as intervisit differences (referenced to median or first visit when n = 2) against mean visual field extent. Differences do not depend strongly on mean level of extent. Dashed lines depict 95% confidence limits for determining significant change between a pair of visits.
Figure 2
Figure 2
Intervisit variability of best-corrected VAs in patients with RPE65-LCA. (A) Multiple visits in different days within an interval of fewer than 85 days are shown ranked by mean VA across visits. Right: Scale indicates equivalent Snellen fractions. (B) Fluctuation around the mean for individual VA data (subtraction of visit data minus mean of all visits for each patient) illustrating the range of variation. (C) Variability shown as intervisit differences (referenced to median or first visit when n = 2) against mean acuity, showing no strong dependence of differences with acuity level. Dashed lines depict 95% confidence limits for determining significant change between two visits. Right: Scale is a correspondence to letters read on an ETDRS chart.

Similar articles

Cited by

References

    1. Jacobson SG, Cideciyan AV. Treatment possibilities for retinitis pigmentosa. N Engl J Med. 2010; 363: 1669–1671 - PubMed
    1. Cideciyan AV. Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy. Prog Retin Eye Res. 2010; 29: 398–427 - PMC - PubMed
    1. Fishman GA, Jacobson SG, Alexander KR, et al. Outcome measures and their application in clinical trials for retinal degenerative diseases: outline, review, and perspective. Retina. 2005; 25: 772–777 - PubMed
    1. Bramall AN, Wright AF, Jacobson SG, McInnes RR. The genomic, biochemical, and cellular responses of the retina in inherited photoreceptor degenerations and prospects for the treatment of these disorders. Annu Rev Neurosci. 2010; 33: 441–472 - PubMed
    1. Wright AF, Chakarova CF, Abd El-Aziz MM, Bhattacharya SS. Photoreceptor degeneration: genetic and mechanistic dissection of a complex trait. Nat Rev Genet. 2010; 11: 273–284 - PubMed

Publication types

MeSH terms